
Global Metagenomics Market Report and Forecast 2024-2032
Description
Global Metagenomics Market Report and Forecast 2024-2032
Global Metagenomics Market Report and Forecast 2024-2032
Global Metagenomics Market Outlook
The global metagenomics market size is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032, driven by increasing interest in exploring the human microbiome, soil microbiome, and other environmental microbiomes across the globe.
Metagenomics: Introduction
Metagenomics is a revolutionary field that involves analyzing the collective genetic material from environmental samples, bypassing the need for isolating and cultivating individual species. This approach allows scientists to study complex microbial communities directly in their natural habitats, uncovering a vast diversity of organisms, many of which are otherwise difficult or impossible to grow in the lab. Metagenomics not only reveals how these microorganisms interact and function but also opens doors to discovering novel genes and biochemical pathways.
Key Trends in the Global Metagenomics Market
Continuous improvements in high-throughput sequencing technologies and bioinformatics tools are significantly enhancing the efficiency and accuracy of metagenomic analyses. This trend is enabling deeper insights into microbial communities and their functions.
There's an increasing interest in exploring the human microbiome, soil microbiome, and other environmental microbiomes. This trend is driven by a growing understanding of the profound impact that microorganisms have on human health, environmental health, and agricultural productivity.
The metagenomics field is becoming integral in drug discovery, development of novel enzymes, and bioremediation processes. Companies are investing in metagenomic approaches to harness the potential of microbial communities for developing new products and solutions.
There's a rising application of metagenomics in agriculture for soil health analysis, crop protection, and yield enhancement. This trend is driven by the need for sustainable agricultural practices and the desire to reduce chemical inputs.
As the field grows, there is an increasing focus on the ethical, legal, and social implications of metagenomic research. Issues related to data privacy, biosafety, and bioethical considerations are becoming more prominent.
The complexity of metagenomic data analysis is fostering collaborations between academic institutions, government agencies, and private entities. These partnerships are crucial for advancing research and translating findings into practical applications.
The demand for skilled professionals in the field of metagenomics is leading to the development of specialized training programs and courses, aiming to equip the workforce with the necessary expertise in bioinformatics and data analysis.
Global Metagenomics Market Segmentation
Market Breakup by Product and Services
- Software
- Kits and Reagents
- Sequencing and Data Analytics Service
- Shotgun Sequencing
- 16S Sequencing
- Whole Genome Sequencing
- Others
- Environmental Application
- Clinical Diagnostics Applications
- Soil Microbiome Applications
- Drug Discovery Applications
- Biotechnology Applications
- Food and Nutrition Applications
- Veterinary Applications
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America, particularly the United States, dominates in technological innovation and research funding, There's a strong emphasis on drug discovery, personalized medicine, and environmental conservation, propelling advanced metagenomic applications.
Europe market is characterized by robust research initiatives and collaborations, especially within the EU framework programs. Countries like Germany, the UK, and France focus on integrating metagenomics into healthcare, agriculture, and bioenergy sectors.Asia-Pacific is a rapidly growing market, with countries like China, Japan, and India investing heavily in biotechnology and bioinformatics. The region shows increasing interest in applying metagenomics for agricultural improvement, disease surveillance, and biodiversity studies.
Latin America growth is driven by biodiversity research and the application of metagenomics in agriculture and environmental monitoring, with countries like Brazil and Mexico taking the lead.
Middle East & Africa market is emerging, with a focus on healthcare applications and infectious disease research. Countries are increasingly investing in genomics and bioinformatics infrastructure to harness the potential of metagenomics.
Global Metagenomics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Agilent Technologies, Inc
- ENTEROME
- IntegraGen
- Oxford Nanopore Technologies
- QIAGEN
- Illumina, Inc
- Pacific Biosciences of California, Inc
- Swift Biosciences Inc.
- Thermo Fisher Scientific Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Computomics Gmbh.
- Microsynth AG
- Arc Bio LLC
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Metagenomics Market Overview
- 3.1 Global Metagenomics Market Historical Value (2017-2023)
- 3.2 Global Metagenomics Market Forecast Value (2027-2032)
- 4 Global Metagenomics Market Landscape
- 4.1 Global Metagenomics Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Metagenomics Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Metagenomics Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Metagenomics Market Segmentation
- 6.1 Global Metagenomics Market by Product and Services
- 6.1.1 Market Overview
- 6.1.2 Software
- 6.1.3 Kits and Reagents
- 6.1.4 Sequencing and Data Analytics Services
- 6.2 Global Metagenomics Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Shotgun Sequencing
- 6.2.3 16S Sequencing
- 6.2.4 Whole Genome Sequencing
- 6.2.5 Others
- 6.3 Global Metagenomics Market by Application
- 6.3.1 Market Overview
- 6.3.2 Environmental Application
- 6.3.3 Clinical Diagnostics Applications
- 6.3.4 Soil Microbiome Applications
- 6.3.5 Drug Discovery Applications
- 6.3.6 Biotechnology Applications
- 6.3.7 Food and Nutrition Applications
- 6.3.8 Veterinary Applications
- 6.3.9 Others
- 6.4 Global Metagenomics Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Metagenomics Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Metagenomics Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Metagenomics Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Metagenomics Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Metagenomics Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Agilent Technologies, Inc
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 ENTEROME
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 IntegraGen
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Oxford Nanopore Technologies
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 QIAGEN
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Illumina, Inc
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Pacific Biosciences of California, Inc
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Swift Biosciences Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Thermo Fisher Scientific Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 BGI
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Bio-Rad Laboratories, Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Promega Corporation
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Computomics Gmbh.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Microsynth AG
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Arc Bio LLC
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Metagenomics Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.